RJFSA
USNA icon

Raymond James Financial Services Advisors’s Usana Health Sciences USNA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,821
Closed -$801K – 3419
2021
Q2 		$801K Buy
+7,821
New +$785K ﹤0.01% 2095

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raymond James Financial Services Advisors's USNA Position: Q3 2021 in Review

Raymond James Financial Services Advisors sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 7,821 shares — an estimated $801K sold.

Raymond James Financial Services Advisors first reported a position in USNA in Q2 2021 and held it in 1 quarter. The position peaked at $801K in Q2 2021. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Raymond James Financial Services Advisors reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 7,821 Usana Health Sciences shares in Q3 2021, an estimated $801K.
  • Raymond James Financial Services Advisors first reported a position in Usana Health Sciences in Q2 2021 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's Usana Health Sciences position peaked at $801K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.